Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children

Completed · Phase 3

Conditions studied: Pain

In brief

The purpose of this study is to characterize the safety, PK, and efficacy of BTDS in patients of ages 7 to 16 years.

Key facts

Study ID
NCT01324570
Run by
Purdue Pharma LP
People needed
41
Starts
2011-07-01
Expected to finish
2016-05-01
Last updated by the study team
2017-07-06

Who can join

Age: 7 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.